Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers.

Abstract:

AIMS:The study was carried out in order to assess the effects of gender and the use of oral contraceptives (OCs) on CYP2D6 and CYP2C19 activities in healthy volunteers. METHODS:Six hundred and eleven Caucasian volunteers (330 males and 281 females; age range 18-49 years) were phenotyped with respect to CYP2D6 and CYP2C19 by means of the probe drugs dextromethorphan and mephenytoin, respectively. Extensive metabolisers were selected for this study. RESULTS:The median dextromethorphan/dextrorphan metabolic ratio in non-OC using females was significantly lower than in males (0.067 vs 0.080; P = 0.033) (mean difference in ln dextromethorphan/dextrorphan metabolic ratio 0.023, 95% CI 0.03-0.43). For the mephenytoin S/R ratio, no such difference was observed. However, OC using females had a significantly higher median mephenytoin S/R ratio than non-OC using females (0.230 vs 0.090; P < 0.001) (mean difference in ln mephenytoin S/R ratio 0.082, 95% CI 0.60-1.04). Moreover, females using combined OCs had a significantly higher median ratio than females using OCs with progestins only (median 0.258 vs 0.135; P = 0.008) (mean difference in ln mephenytoin S/R ratio 0.82, 95% CI 0.21-1.34). CONCLUSIONS:Given certain assumptions, the study indicates that females in the fertile age have a slightly higher CYP2D6 activity compared with males. There was no evidence of a gender difference in CYP2C19 activity. The use of combined OCs reduces the activity of CYP2C19, an effect that seems to be related to the ethinyloestradiol component.

journal_name

Br J Clin Pharmacol

authors

Hägg S,Spigset O,Dahlqvist R

doi

10.1111/j.1365-2125.2001.01328.x

keywords:

subject

Has Abstract

pub_date

2001-02-01 00:00:00

pages

169-73

issue

2

eissn

0306-5251

issn

1365-2125

pii

bcp328

journal_volume

51

pub_type

临床试验,杂志文章
  • Does the European clinical trials directive really improve clinical trial approval time?

    abstract:AIMS:To facilitate and improve clinical research within Europe, the European Union (EU) adopted in 2001 the Clinical Trials Directive (EUCTD). The aim of this study was to compare duration between submission of a clinical drug trial application and approval by regulatory authorities in EU countries regulated by EUCTD v...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究

    doi:10.1111/j.1365-2125.2008.03246.x

    authors: Lambers Heerspink HJ,Dobre D,Hillege HL,Grobbee DE,de Zeeuw D

    更新日期:2008-10-01 00:00:00

  • 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

    abstract::1 Theories linking 5-hydroxytryptamine (5-HT) with depression are briefly reviewed. The various experimental strategies adopted to investigate this relationship, examination of autopsy data, CSF metabolite data, 5-HT re-uptake patterns in human blood platelets and imipramine binding studies in human platelets, are dis...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1983.tb02130.x

    authors: Goodwin FK,Post RM

    更新日期:1983-01-01 00:00:00

  • Lead poisoning: case studies.

    abstract::Early clinical features of lead toxicity are non-specific and an occupational history is particularly valuable. Lead in the body comprises 2% in the blood (t1/2 35 days) and 95% in bone and dentine (t1/2 20-30 years). Blood lead may remain elevated for years after cessation from long exposure, due to redistribution fr...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.2002.01580.x

    authors: Gordon JN,Taylor A,Bennett PN

    更新日期:2002-05-01 00:00:00

  • Evaluation of long-term treatment of essential hypertension with guanfacine.

    abstract::1. Twenty-two patients with moderately severe essential hypertension were treated for a period of 12 months with guanfacine (BS 100-141), a new centrally-acting antihypertensive agent. A twice daily schedule was followed and the dose range of guanfacine was 1-8 mg daily. 2. In twenty patients satisfactory blood pressu...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1980.tb04906.x

    authors: Higuchi M,Overlack A,Stumpe KO

    更新日期:1980-01-01 00:00:00

  • A comparative study of atenolol and metoprolol in the treatment of hypertension.

    abstract::1 In an open, randomized cross-over investigation of thirteen patients (nine and four women, aged 37-67 years) with mild or moderate essential hypertension a comparison between atenolol and metoprolol was carried out in order to study the effects of 50, 100 and 200 mg given once daily on blood pressure and heart rate ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1981.tb01326.x

    authors: Rasmussen S,Arnung K,Eskildsen PC,Nielsen PE

    更新日期:1981-12-01 00:00:00

  • Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciatica.

    abstract:AIMS:BG00010 is a protein in the glial cell line-derived neurotrophic factor (GDNF) family. It is a selective ligand for the GDNF family receptor alpha-3 (GFRα3) co-receptor that normalizes cellular changes resulting from damage or disease, and potentially alleviates neuropathic pain. The main objectives of this study ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/bcp.12941

    authors: Okkerse P,Hay JL,Versage E,Tang Y,Galluppi G,Ravina B,Verma A,Williams L,Aycardi E,Groeneveld GJ

    更新日期:2016-07-01 00:00:00

  • The pharmacokinetics of fluconazole after a single intravenous dose in AIDS patients.

    abstract::The pharmacokinetics of fluconazole after a single 100 mg i.v. dose were studied in 10 healthy subjects (5 M; 5 F) and 10 HIV-positive patients (8 M; 2 F). The mean value of plasma clearance was 25% lower in the patient groups (17 +/- 6 (s.d.) vs 23 +/- 4 ml min-1; 95% CI of difference -11 to -0.7; P < 0.05). This dif...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2125.1994.tb04325.x

    authors: Yeates RA,Ruhnke M,Pfaff G,Hartmann A,Trautmann M,Sarnow E

    更新日期:1994-07-01 00:00:00

  • Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.

    abstract::Medroxalol, a new drug which has been reported to possess both alpha- and beta-adrenoceptor antagonist properties, was compared with labetalol in single dose studies in normotensive males. Oral doses of 400 mg of each drug significantly reduced blood pressure, both supine and erect, without significant changes in hear...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1984.tb02391.x

    authors: Elliott HL,McLean K,Meredith PA,Sumner DJ,Reid JL

    更新日期:1984-05-01 00:00:00

  • Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans.

    abstract:AIMS:Endothelins (ETs) may play a role in the pathogenesis of a variety of cardiovascular diseases. The present study was designed to investigate the pharmacokinetic and pharmacodynamic effects of the orally active ETA selective receptor antagonist ABT-627 in healthy humans. METHODS:Healthy volunteers were included in...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1046/j.1365-2125.2000.00171.x

    authors: Verhaar MC,Grahn AY,Van Weerdt AW,Honing ML,Morrison PJ,Yang YP,Padley RJ,Rabelink TJ

    更新日期:2000-06-01 00:00:00

  • Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.

    abstract:AIMS:To investigate the driving forces behind increasing utilization of cardiovascular drugs. METHODS:Using register data, all Danish residents as of 1 January 1996 were followed until 2006. Cohort members were censored at death or emigration. Cardiovascular drug utilization on the individual level was traced, applyin...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究

    doi:10.1111/j.1365-2125.2008.03282.x

    authors: Kildemoes HW,Støvring H,Andersen M

    更新日期:2008-12-01 00:00:00

  • Effect of allopurinol on caffeine disposition in man.

    abstract::Caffeine (5 mg kg-1) was administered orally to two healthy, non-smoking subjects on three separate occasions--before, and during therapy with the xanthine oxidase inhibitor allopurinol at doses of either 300 or 600 mg daily. Plasma and urinary levels of methylxanthines, endogenous oxypurines and allopurinol and its m...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1986.tb05222.x

    authors: Grant DM,Tang BK,Campbell ME,Kalow W

    更新日期:1986-04-01 00:00:00

  • The roles of clinical pharmacologists in UK universities.

    abstract::Clinical pharmacologists in universities play major roles in research and teaching and provide important contributions to National Health Service (NHS) activities, such as work for research ethics, drug and therapeutics, and clinical governance committees. Their research extends from preclinical studies using drugs to...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2012.04228.x

    authors: Webb DJ

    更新日期:2012-06-01 00:00:00

  • Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis.

    abstract:AIMS:The aim was to examine relationships between total and unbound mycophenolic acid (MPA) and prednisolone exposure and clinical outcomes in patients with lupus nephritis. METHODS:Six blood samples were drawn pre- and at 1, 2, 4, 6 and 8 h post-dose and total and unbound MPA and prednisolone pre-dose (C0 ), maximum ...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/bcp.12678

    authors: Abd Rahman AN,Tett SE,Abdul Gafor HA,McWhinney BC,Staatz CE

    更新日期:2015-11-01 00:00:00

  • Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field.

    abstract::1. A survey has been conducted amongst 459 members of the Clinical Section of the British Pharmacological Society to ascertain facts about the administration of drugs to healthy volunteers over the period October 1986 to September 1987. 2. A response rate of 87.1% was obtained with 114 individuals being involved in he...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1989.tb05342.x

    authors: Orme M,Harry J,Routledge P,Hobson S

    更新日期:1989-02-01 00:00:00

  • City checking: Piloting the UK's first community-based drug safety testing (drug checking) service in 2 city centres.

    abstract:AIMS:To explore the feasibility of delivering community-based drug safety testing (drug checking), to trial service design characteristics and to compare with festival-based testing. METHODS:In total, 171 substances of concern were submitted on 5 dates at 3 venues in 2 UK cities and tested using up to 6 analytical tec...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.14231

    authors: Measham F

    更新日期:2020-03-01 00:00:00

  • Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism.

    abstract:AIMS:To obtain in vivo evidence for the involvement of cytochrome P450 (CYP) 3A4 in the metabolism of brotizolam. METHODS:Fourteen healthy male volunteers received erythromycin 1200 mg day(-1) or placebo for 7 days in a double-blind randomized crossover manner. On the 6th day they received a single oral 0.5-mg dose of...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.2005.02380.x

    authors: Tokairin T,Fukasawa T,Yasui-Furukori N,Aoshima T,Suzuki A,Inoue Y,Tateishi T,Otani K

    更新日期:2005-08-01 00:00:00

  • Drug resistance, inappropriate dosing and non-compliance in hypertensive patients.

    abstract::1 From an understanding of the biological fate and hypotensive effect of debrisoquine (D) we have assessed the relative importance of true drug resistance, inappropriately low dosage and non-compliance as causes of apparent resistance to treatment with this drug. 2 Among 37 hypertensive patients prescribed D, eleven (...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1980.tb01072.x

    authors: Silas JH,Tucker GT,Smith AJ

    更新日期:1980-04-01 00:00:00

  • Antipyrine elimination in saliva after low-dose combined or progestogen-only oral contraceptive steroids.

    abstract::1 A 'low-dose' combined oral contraceptive steroid (OCS) preparation containing 30 microgram ethinylo-estradiol and 150 microgram levonorgestrel was found to reduce significantly antipyrine clearance in a group of women acting as their own controls. 2 An OCS preparation containing only a progestogen (75 microgram norg...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1982.tb01362.x

    authors: Chambers DM,Jefferson GC,Chambers M,Loudon NB

    更新日期:1982-02-01 00:00:00

  • Clinical pharmacological studies with prazosin during pregnancy complicated by hypertension.

    abstract::The disposition and effect of orally administered prazosin have been studied in eight women with hypertension which was uncontrolled by beta-adrenoceptor blockade during the last trimester of pregnancy. Results were compared with healthy men of similar age. The median time to peak concentration was 165 min during preg...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1983.tb02213.x

    authors: Rubin PC,Butters L,Low RA,Reid JL

    更新日期:1983-11-01 00:00:00

  • Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes.

    abstract::1. The beta-adrenergic blocking potencies of practolol, ICI 66082, tolamolol, acebutolol, H 93/26, H 87/07, pindolol and Ro 3-4787 were compared with that of propranolol, on human and rat adipocytes. 2. A good correlation was found between the potencies on adipocytes of the two species but not between our results and ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1975.tb02776.x

    authors: Harms HH,Van der Meer J

    更新日期:1975-08-01 00:00:00

  • Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.

    abstract:AIMS:Our goal was to evaluate the association between antidepressant use and the risk of coronary heart disease (CHD) among subjects with no history of coronary heart disease. METHODS:A search of Medline, EMBASE, PsycINFO and the Cochrane Library was performed in January 2013. Two authors independently reviewed and se...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章,meta分析

    doi:10.1111/bcp.12383

    authors: Oh SW,Kim J,Myung SK,Hwang SS,Yoon DH

    更新日期:2014-10-01 00:00:00

  • Paracetamol metabolism in pregnancy.

    abstract::Paracetamol disposition was studied in groups of pregnant and non-pregnant women of comparable age. Paracetamol apparent oral clearance was 58% higher and elimination half-life was 28% lower in the pregnant women compared to the control group. The higher clearance in the pregnant women was due to increased activity of...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.1986.tb02901.x

    authors: Miners JO,Robson RA,Birkett DJ

    更新日期:1986-09-01 00:00:00

  • Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe.

    abstract:AIMS:The aims of the present study were to describe the consumption trends of three groups of analgesics (non-opioids, and mild and strong opioids) between 2006 and 2015 in France, and compare this pattern of use with six European countries in 2015. METHODS:Annual drugs sales were extracted from the French national au...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.13564

    authors: Hider-Mlynarz K,Cavalié P,Maison P

    更新日期:2018-06-01 00:00:00

  • Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin.

    abstract:AIMS:Changes in both digoxin and aciclovir renal clearance following coadministration with some other renally eliminated drugs have been reported. The potential interaction of valaciclovir, with its antiherpetic metabolite aciclovir, and digoxin was investigated. METHODS:Twelve healthy volunteers (seven males, five fe...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2125.1998.00649.x

    authors: Soul-Lawton JH,Weatherley BC,Posner J,Layton G,Peck RW

    更新日期:1998-01-01 00:00:00

  • Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.

    abstract::1 The effect of an intravenous bolus of labetalol (0.6--1.6 mg/kg body weight) on central and peripheral haemodynamics was studied in nine subjects with essential hypertension and in eleven subjects with chronic renal disease and hypertension. 2 The BP reduction amounting to 20/13 mmHg was entirely due to the lowering...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:

    authors: Bahlmann J,Brod J,Hubrich W,Cachovan M,Pretschner P

    更新日期:1979-01-01 00:00:00

  • The effect of nicardipine on pituitary hormone release in normal volunteers.

    abstract::In a double-blind, placebo-controlled, randomised, cross-over study of six healthy male subjects, the effect of nicardipine (5 mg h-1 for 3 h) on basal and stimulated pituitary hormone release was examined. Statistically significant differences between nicardipine and placebo were seen occasionally for follicle-stimul...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2125.1985.tb05147.x

    authors: Isles TE,Baty J,Dow RJ

    更新日期:1985-01-01 00:00:00

  • Under-reporting of adverse drug reactions in general practice.

    abstract:AIMS:In post-marketing setting, spontaneous reporting by physicians is a mode of surveillance of adverse effects associated with drug use. The objective of this study was to quantitatively assess under-reporting of adverse drug reactions (ADRs) in general practice. METHODS:A random sample of 100 general practitioners ...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2125.1997.05417.x

    authors: Moride Y,Haramburu F,Requejo AA,Bégaud B

    更新日期:1997-02-01 00:00:00

  • Assessment of potential drug interactions by characterization of human drug metabolism pathways using non-invasive bile sampling.

    abstract:AIM:Characterization of the biliary disposition of GSK1325756, using a non-invasive bile sampling technique and spectrometric analyses, to inform the major routes of metabolic elimination and to enable an assessment of victim drug interaction risk. METHOD:Sixteen healthy, elderly subjects underwent non-invasive bile c...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2125.2012.04352.x

    authors: Bloomer JC,Nash M,Webb A,Miller BE,Lazaar AL,Beaumont C,Guiney WJ

    更新日期:2013-02-01 00:00:00

  • Long-term trajectories of medicine use among older adults experiencing polypharmacy in Australia.

    abstract:AIMS:To explore longitudinal changes in the number and type of medicines used among older people who experience polypharmacy. METHODS:We used pharmaceutical claims for a 10% sample of Australian Pharmaceutical Benefits Scheme beneficiaries to identify people aged 70 years and older who were exposed to 5 or more medici...

    journal_title:British journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1111/bcp.14504

    authors: Falster MO,Charrier R,Pearson SA,Buckley NA,Daniels B

    更新日期:2020-07-31 00:00:00

  • Drug disposition before and after gastric bypass: fenofibrate and posaconazole.

    abstract:AIMS:Roux-en-Y gastric bypass (RYGB) alters the anatomical structure of the gastrointestinal tract, which can result in alterations in drug disposition. The aim of the present study was to evaluate the oral disposition of two compounds belonging to the Biopharmaceutical Classification System Class II - fenofibrate (bil...

    journal_title:British journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1111/bcp.13054

    authors: Gesquiere I,Hens B,Van der Schueren B,Mols R,de Hoon J,Lannoo M,Matthys C,Foulon V,Augustijns P

    更新日期:2016-11-01 00:00:00